Onderneming Syngene International Limited Bombay S.E.
Aandelen
SYNGENE
INE398R01022
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
678,7 INR | -1,27% | -2,90% | -3,20% |
26/04 | SYNGENE INTERNATIONAL LIMITED : Jefferies & Co. verlaagt advies van Neutraal naar Verkopen | ZM |
25/04 | Transcript : Syngene International Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
Vakgebied
Aantal werknemers: 6 847
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Contract Research and Manufacturing Services
96,5
%
| 25 067 | 96,3 % | 30 802 | 96,5 % | +22,88% |
Others
3,4
%
| 953 | 3,7 % | 1 077 | 3,4 % | +13,01% |
Scrap
0,2
%
| 22 | 0,1 % | 50 | 0,2 % | +127,27% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
71,8
%
| 18 782 | 72,1 % | 22 918 | 71,8 % | +22,02% |
Europe
17,9
%
| - | - | 5 711 | 17,9 % | - |
Rest of the World
6,5
%
| 4 471 | 17,2 % | 2 083 | 6,5 % | -53,41% |
India
3,8
%
| 2 789 | 10,7 % | 1 217 | 3,8 % | -56,36% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jonathan Hunt
CEO | Chief Executive Officer | 55 | 01-03-15 |
Sibaji Biswas
DFI | Director of Finance/CFO | - | 18-12-19 |
Chairman | 71 | 18-11-94 | |
Compliance Officer | - | 24-07-19 | |
Krishnan G.
IRC | Investor Relations Contact | - | 01-05-20 |
Andrew Webster
HRO | Human Resources Officer | - | 01-12-22 |
Alok Mehrotra
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01-01-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 71 | 18-11-94 | |
Director/Board Member | 67 | 31-07-17 | |
Jonathan Hunt
CEO | Chief Executive Officer | 55 | 01-03-15 |
Kush Parmar
BRD | Director/Board Member | 42 | 22-06-21 |
Paul Blackburn
BRD | Director/Board Member | 70 | 26-08-14 |
Director/Board Member | 63 | 08-08-00 | |
Director/Board Member | 68 | 01-03-17 | |
Director/Board Member | 59 | 01-08-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 402 536 981 | 179 731 177 ( 44,65 %) | 1 243 697 ( 0,3090 %) | 44,65 % |
Bedrijfsgegevens
Syngene International Ltd.
Biocon Park, Biocon SEZ Bommasandra Indl Area, IV Phase
560099, Bangalore
+91 80 6891 9191
http://www.syngeneintl.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Syngene Scientific Solutions Ltd.
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 48,09 mld. | |
+46,90% | 40,62 mld. | |
-3,46% | 40,43 mld. | |
-6,20% | 28,36 mld. | |
+9,17% | 24,89 mld. | |
-20,42% | 19,01 mld. | |
+28,07% | 12,09 mld. | |
+0,17% | 11,88 mld. | |
-1,24% | 11,8 mld. |
- Beurs
- Aandelen
- Koers SYNGENE
- Koers SYNGENE
- Onderneming Syngene International Limited